elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38857067-423FFDC3-7F6D-4D03-AAB8-3416E05EA3B2
Q38857067-423FFDC3-7F6D-4D03-AAB8-3416E05EA3B2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38857067-423FFDC3-7F6D-4D03-AAB8-3416E05EA3B2
Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML.
P2860
Q38857067-423FFDC3-7F6D-4D03-AAB8-3416E05EA3B2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38857067-423FFDC3-7F6D-4D03-AAB8-3416E05EA3B2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0e2959faebb7de532c51a672e0c1e2e28e00df8d
P2860
Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia